Results 181 to 190 of about 14,338 (204)
Some of the next articles are maybe not open access.

Medulloblastoma and primitive neuroectodermal tumors

2012
Medulloblastomas and sPNETs remain highly problematic tumors to treat. Prognosis has improved over the past two decades, but many children who survive treatment have significant long-term sequelae. The improvements in outcome have been due to advances in surgical techniques, the wider use of chemotherapy, and the more judicious use of radiotherapy. For
Roger J, Packer   +4 more
openaire   +2 more sources

Primitive Neuroectodermal Tumors and Ewingʼs Sarcoma

The American Journal of Surgical Pathology, 1992
Many of the major solid, malignant tumors of childhood have histologic similarities that reflect their dysembryonic and primitive features. One subset of these neoplasms, Ewing's sarcoma (ES) and primitive neuroectodermal tumor (PNET), presents primarily in the bone and soft tissues.
openaire   +2 more sources

Peripheral Primitive Neuroectodermal Tumor

2020
Primitive neuroectodermal tumor (PNET) is a family of small round cell malignancies originating from primitive neuroectodermal (hence the name) cells including the following entities: peripheral primitive neuroectodermal tumor (peripheral PNET, pPNET), central PNET (or PNET of the central nervous system, cPNET; in the past it included medulloblastoma),
openaire   +2 more sources

Primitive neuroectodermal tumors

Human Pathology, 1984
F A, Beemer, G E, Staal
openaire   +2 more sources

Renal Primitive Neuroectodermal Tumor

Journal of Urology, 2012
Suraj, Gupta   +2 more
openaire   +2 more sources

Primitive Neuroectodermal Tumor

2016
Hariqbal Singh, Yasmeen Khan
openaire   +2 more sources

Primitive Neuroectodermal Tumors

The American Journal of Surgical Pathology, 2003
Sanjay A. Pai   +2 more
openaire   +1 more source

Primitive Neuroectodermal Tumors

2011
Karin Muraszko, Shawn L. Hervey-Jumper
openaire   +1 more source

Primitive neuroectodermal tumors.

Plastic & Reconstructive Surgery, 1999
openaire   +1 more source

Home - About - Disclaimer - Privacy